Skip to main content
SpringerLink
Log in

Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes

  • Letter to the Editors
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Tremblay A, Chaput JP, Berube-Parent S, Prud’homme D, Leblanc C, Almeras N et al (2007) The effect of topiramate on energy balance in obese men: a 6-month double-blind randomized placebo-controlled study with a 6-month open-label extension. Eur J Clin Pharmacol 63(2):123–134

    Article  PubMed  CAS  Google Scholar 

  2. Appolinario JC, Bacaltchuk J, Sichieri R, Claudino AM, Godoy-Matos A, Morgan C et al (2003) A randomized, double-blind, placebo-controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry 60(11):1109–1116

    Article  PubMed  CAS  Google Scholar 

  3. Fedoroff I, Polivy J, Herman CP (2003) The specificity of restrained versus unrestrained eaters’ responses to food cues: general desire to eat, or craving for the cued food? Appetite 41(1):7–13

    Article  PubMed  Google Scholar 

  4. Backstrom P, Hyytia P (2003) Attenuation of cocaine-seeking behaviour by the AMPA/kainate receptor antagonist CNQX in rats. Psychopharmacology (Berl) 166(1):69–76

    Google Scholar 

  5. Gibbs JW III, Sombati S, DeLorenzo RJ, Coulter DA (2000) Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 (Suppl 1):S10–S16

    Article  PubMed  CAS  Google Scholar 

  6. Johnson BA, Ait-Daoud N, Bowden CL, DiClemente CC, Roache JD, Lawson K et al (2003) Oral topiramate for treatment of alcohol dependence: a randomised controlled trial. The Lancet 361(9370):1677–1685

    Article  CAS  Google Scholar 

  7. Khazaal Y, Cornuz J, Bilancioni R, Zullino DF (2006) Topiramate for smoking cessation. Psychiatry Clin Neurosci 60(3):384–388

    Article  PubMed  CAS  Google Scholar 

  8. Khazaal Y, Zullino DF (2006) Topiramate in the treatment of compulsive sexual behavior: case report. BMC Psychiatry 6:22

    Article  PubMed  Google Scholar 

  9. Dannon PN, Lowengrub K, Gonopolski Y, Musin E, Kotler M (2005) Topiramate versus fluvoxamine in the treatment of pathological gambling: a randomized, blind-rater comparison study. Clin Neuropharmacol 28(1):6–10

    Article  PubMed  CAS  Google Scholar 

  10. McElroy SL, Shapira NA, Arnold LM, Keck PE, Rosenthal NR, Wu SC et al (2004) Topiramate in the long-term treatment of binge-eating disorder associated with obesity. J Clin Psychiatry 65(11):1463–1469

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d’abus de substances, Hôpitaux Universitaires de Genève, Rue verte 2, 1205, Genève, Switzerland

    Yasser Khazaal & Daniele Fabio Zullino

Authors
  1. Yasser Khazaal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniele Fabio Zullino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniele Fabio Zullino.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khazaal, Y., Zullino, D.F. Topiramate-induced weight loss is possibly due to the blockade of conditioned and automatic processes. Eur J Clin Pharmacol 63, 891–892 (2007). https://doi.org/10.1007/s00228-007-0318-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-007-0318-0

Keywords

Search

Navigation